GlaxoSmithKline Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 9,569.9 million compared to INR 9,168.7 million a year ago. Revenue was INR 9,852 million compared to INR 9,388.4 million a year ago. Net income was INR 2,175.1 million compared to INR 1,934.2 million a year ago. Basic earnings per share from continuing operations was INR 12.84 compared to INR 11.42 a year ago. Basic earnings per share was INR 12.84 compared to INR 11.42 a year ago.
For the six months, sales was INR 17,186.5 million compared to INR 16,619.7 million a year ago. Revenue was INR 17,833 million compared to INR 17,115.5 million a year ago. Net income was INR 3,497.6 million compared to INR 3,127 million a year ago. Basic earnings per share from continuing operations was INR 19.88 compared to INR 18.28 a year ago. Basic earnings per share was INR 19.88 compared to INR 18.46 a year ago.